TRAIL and IP-10 as biomarkers of viral infections in the emergency department

Journal of Infection

Volumn 72, Issue 6, 2016, Pages 761-763

  van der Does, Yuri ^a   Tjikhoeri, Anisha ^a   Ramakers, Christian ^a   Rood, Pleunie P M ^a   van Gorp, Eric C M ^a   Limper, Maarten ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROCALCITONIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADENOVIRIDAE; ADENOVIRUS INFECTION; AREA UNDER THE CURVE; BACTERIAL INFECTION; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DIFFERENTIAL DIAGNOSIS; EMERGENCY WARD; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FEVER; GOUT; GROUP B STREPTOCOCCAL INFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; INFLAMMATORY DISEASE; INFLUENZA; INFLUENZA A; INFLUENZA A VIRUS; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LEGIONELLA; LEGIONNAIRE DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; MICROCOCCUS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NEUROLEPTIC MALIGNANT SYNDROME; PARAINFLUENZA VIRUS INFECTION; PARAMYXOVIRINAE; PNEUMOCOCCAL INFECTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECEIVER OPERATING CHARACTERISTIC; RHINOVIRUS; RHINOVIRUS INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION; HOSPITAL EMERGENCY SERVICE;

BIOMARKERS; CHEMOKINE CXCL10; EMERGENCY SERVICE, HOSPITAL; HUMANS; VIRUS DISEASES;

EID: 84962129706     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.03.004     Document Type: Letter

References (9)

1. Ten Oever J., Netea M.G., Kullberg B.J. Utility of immune response-derived biomarkers in the differential diagnosis of inflammatory disorders. J Infect 2016, 72:1-18.
2. Christ-Crain M., Stolz D., Bingisser R., Muller C., Miedinger D., Huber P.R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84-93.
3. Schuetz P., Christ-Crain M., Thomann R., Falconnier C., Wolbers M., Widmer I., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA J Am Med Assoc 2009, 302:1059-1066.
4. Oved K., Cohen A., Boico O., Navon R., Friedman T., Etshtein L., et al. A novel host-proteome signature for distinguishing between acute bacterial and viral infections. PLoS One 2015, 10:e0120012.
5. Falschlehner C., Schaefer U., Walczak H. Following TRAIL's path in the immune system. Immunology 2009, 127:145-154.
6. Liu M., Guo S., Hibbert J.M., Jain V., Singh N., Wilson N.O., et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev 2011, 22:121-130.
7. Limper M., van der Does Y., Brandjes D.P., De Kruif M.D., Rood P.P., van Gorp E.C. Procalcitonin guided antibiotic therapy in patients presenting with fever in the emergency department. J Infect 2014, 69:410-412.
8. Limper M., de Kruif M.D., Duits A.J., Brandjes D.P., van Gorp E.C. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010, 60:409-416.
9. Limper M., Eeftinck Schattenkerk D., de Kruif M.D., van Wissen M., Brandjes D.P., Duits A.J., et al. One-year epidemiology of fever at the emergency department. Neth J Med 2011, 69:124-128.